Home » Topics » BioWorld Science

BioWorld Science
RSS

Viriom opens phase II study of NNRTI elsulfavirine for COVID-19

April 8, 2020

GPR56 found to be tied with antidepressant treatment response

April 8, 2020

New HDAC6 inhibitors show promise in Charcot-Marie-Tooth disease cell model

April 8, 2020

Selective circadian regulation may yield new therapies

April 8, 2020

Kolon begins first-in-human study of KLS-2031 for neuropathic pain from lumbosacral radiculopathy

April 8, 2020

Emapalumab and anakinra studied to reduce hyperinflammation and respiratory distress in COVID-19

April 8, 2020

FDA clears Polaryx's IND for PLX-200 in juvenile neuronal ceroid lipofuscinosis

April 8, 2020

New nitrofuran-class antibiotic IITR-06144 shows efficacy against resistant bacteria

April 8, 2020

Biogen describes new OGA inhibitors

April 8, 2020

New USP9X inhibitors identified by FORMA Therapeutics

April 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...